Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.01
8% from low
Exchange
OTC Link
CS
Borrow rate
0.29%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $751.0K | $8.6M | $4.5M | $3.0M | $410.0K | $2.7M | $3.6M | $1.6M |
| Cost of revenue | $227.0K | $656.0K | $451.0K | $128.0K | $1.8K | $1.5K | $1.8M | $90.0K |
| Gross profit | $524.0K | $7.9M | $4.0M | $2.8M | $408.2K | $2.7M | $3.6M | $1.5M |
| Gross margin | 69.8% | 92.4% | 89.9% | 95.7% | 99.6% | 99.9% | 99.9% | 94.2% |
| R&D | $4.6M | $2.6M | $4.0M | $3.7M | $1.8M | $1.5M | $1.8M | $1.5M |
| Operating income | −$12.2M | −$4.0M | −$6.6M | −$5.2M | −$3.9M | −$725.0K | −$758.0K | −$1.2M |
| EBITDA | −$11.8M | −$3.6M | −$6.2M | −$4.9M | −$3.2M | −$3.0M | −$633.0K | −$589.0K |
| Net income | −$13.2M | −$5.0M | −$7.4M | −$5.7M | −$3.8M | −$3.8M | −$1.2M | −$879.0K |
| Net margin | -1758.9% | -58.1% | -165.5% | -191.6% | -937.1% | -142.0% | -33.8% | -56.2% |
| EPS (diluted) | -1.35 | -0.46 | -0.62 | -0.36 | -0.18 | -0.14 | -0.04 | -0.02 |
Annual figures · source: Financial Modeling Prep
ACURA PHARMS INC
No one on the platform currently holds ACUR.
No tracked institution reports a position in ACUR as of their last filing.
| Execution date | Ratio |
|---|---|
| 2015-08-28 | 1-for-5reverse |
| 2007-12-05 | 1-for-10reverse |
No one on the platform has traded ACUR yet.
| $26179 |
| — |
| GMVDFG Medical Innovations Holdings Ltd | $0.00 | +0.00% | $25992 | — |
| GNLKQGeneLink, Inc. | $0.00 | +0.00% | $10601 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Fundamental analysis of $ACUR (ACURA PHARMACEUTICALS, INC) based on financial data and reported results. #ACUR #ACURA
View on StockTwits ↗$ACUR https://contracts.justia.com/companies/acura-pharmaceuticals-inc-7140/contract/294147/ Bankruptcy coming??
View on StockTwits ↗$ACUR https://www.pharmacytimes.com/view/because-ned-said-new-technology-helps-prevent-opioid-overdose
View on StockTwits ↗Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
View on StockTwits ↗Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
View on StockTwits ↗Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
View on StockTwits ↗Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
View on StockTwits ↗Acura Pharmaceuticals, Inc. Files SEC Form 10-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
View on StockTwits ↗Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
View on StockTwits ↗Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
View on StockTwits ↗Acura Pharmaceuticals, Inc. Files SEC Form 8-K $ACUR https://www.marketbeat.com/stocks/OTCMKTS/ACUR/sec-filings/
View on StockTwits ↗$MTEK Maris-Tech Enters Into Agreement with Art of Logic Australia for $7.5 Million of a New Product Based On the Company’s Uranus-AI Product $ACUR $NNOX
View on StockTwits ↗$ACUR Form NT 10-K (notification of inability to timely file form 10-k 405, 10-k, 10-ksb 405, 10-ksb, 10-kt, or 10-kt405) filed with the SEC https://newsfilter.io/a/1426511649425ac8ea9893ab457afcb8
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.